Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort(e): Sonstiges Mainz Biomed gibt 6,0 Millionen USD Privatplatzierung und strategisches Update bekannt 17.02.2026 / 15:00 CET/CEST ...
Viele Menschen leiden nach Corona unter Konzentrationsproblemen und verlangsamtem Denken. Eine neue Studie liefert nun ...
The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
During the COVID-19 pandemic, a staggering 340 million tests for the virus were supplied across the world by a company based in South Korea that specializes in so-called syndromic real-time polymerase ...
Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort(e): Sonstiges Mainz Biomed gibt 6,0 Millionen USD Privatplatzierung und strategisches Update bekannt 17.02.2026 / 15:00 ...
Net proceeds from the private placement will be used to fund ongoing operations, address outstanding liabilities, and preserve the company's ability to operate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results